Somatic mutations in the DLG and ETGE motifs of Nrf2, with very high frequency, occur in numerous cancer cells, leading to the disruption of the two-site binding of Keap1–Nrf2 and constitutive accumulation of Nrf2 [34]. Here, NFE2L2 is linked to cancer.